about
Naproxen conjugated mPEG-PCL micelles for dual triggered drug delivery.Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers.Antinociceptive effect of some biuret derivatives on formalin test in mice.Percutaneous absorption of salicylic Acid after administration of trolamine salicylate cream in rats with transcutol(®) and eucalyptus oil pre-treated skin.High-performance liquid chromatographic determination of propofol in human plasma: comparison of different heteroscedastic calibration curve models.Rheological behavior and stability of ciprofloxacin suspension: Impact of structural vehicles and flocculating agent.Optimization of the simultaneous determination of imatinib and its major metabolite, CGP74588, in human plasma by a rapid HPLC method using D-optimal experimental design.Determination of theophylline clearance after cimetidine infusion in critically ill patients.Estimation of abbreviated mycophenolic acid area under the concentration-time curve during early posttransplant period by limited sampling strategy.In vitro antifungal activity of 2-(4-substituted phenyl)-3(2H)-isothiazolones.The effect of preemptive analgesia with bupivacaine on postoperative pain of inguinal hernia repair under spinal anesthesia: a randomized clinical trial.Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia.Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.Non-linear heteroscedastic regression model for determination of methotrexate in human plasma by high-performance liquid chromatographyIncorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model applicationNeuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancementOral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation
P50
Q38797131-35F85209-DC6C-4102-9B0B-5F2CAE4176DAQ40721053-1EC31EC7-4F61-4068-A775-E14BB5409BF2Q41921616-36FE0C02-7635-41BA-BF3A-F49BA76E3F84Q42080183-D9572506-066B-483E-A2E9-E46E3C77036CQ42213605-F8664143-04E8-4C58-9177-0B2B091B86B8Q42636950-E6784242-0DAC-408F-8900-5F3E010ED932Q44471779-659D76FB-59D6-44F0-91D4-521BE081D539Q44517775-36869700-0E6B-49B4-ADB1-3445EA7AA9F8Q46187819-0FE14AD6-CF2E-4133-A2B2-DEEC8CA1E7D6Q46616865-3B41B809-F818-4471-93A4-4D52A163E9ECQ48120030-FB13B0B9-4DBE-4633-A5EE-E9EEE9F3BCEFQ51088241-2B5F9005-9921-4EAC-B759-ED09873C10F3Q51514772-9EF45C09-3016-41AB-9293-C401DE705D45Q73157901-02AF1F23-7FFB-4E9F-B786-5D18F08CB537Q79631767-116699DB-5CD1-4573-8BEB-81176D4B08C4Q91034973-168F171B-0A5F-47BC-B9B9-E178D6F076C5Q92475423-44FA62B9-F985-42FA-89CA-C91155853022
P50
description
researcher
@en
հետազոտող
@hy
name
Saeed Rezaee
@ast
Saeed Rezaee
@en
Saeed Rezaee
@es
Saeed Rezaee
@nl
Saeed Rezaee
@sl
type
label
Saeed Rezaee
@ast
Saeed Rezaee
@en
Saeed Rezaee
@es
Saeed Rezaee
@nl
Saeed Rezaee
@sl
prefLabel
Saeed Rezaee
@ast
Saeed Rezaee
@en
Saeed Rezaee
@es
Saeed Rezaee
@nl
Saeed Rezaee
@sl
P106
P1153
8943536700
P31
P496
0000-0001-9009-9590